Advertisements



Woodlands-based pharma co. to receive $260M in drug dispute settlement

The Woodlands-based Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) will receive $260 million in a settlement payment related to one of its drug candidates. French pharmaceutical company Sanofi SA (Nasdaq: SNY) will pay Lexicon Pharmaceuticals $260 mi.....»»

Category: topSource: bizjournalsSep 11th, 2019

Danish Company To Buy Migraine Drug Developer Alder Biopharma In Deal Worth Up To $1.95B

Merger Monday dawned with Danish pharma company Lundbeck announcing a definitive agreement to buy U.S.-based Alder Biopharmaceuticals Inc (NASDAQ: ALDR). read more.....»»

Category: blogSource: benzingaSep 16th, 2019

OxyContin Producer Purdue Pharma Reaches Tentative Opioid-Crisis Settlement

Sources say that Connecticut-based Purdue will pay up to $12 billion over time (HARTFORD, Conn.) — Nearly half the states and some 2,000 local governments have agreed to a tentative settlement with OxyContin m.....»»

Category: topSource: timeSep 11th, 2019

Troubled Chandler pharma company sells off drug assets as part of bankruptcy

Insys Therapeutics Inc, has entered into sales agreements to unload some of its drug assets for a combined $29.2 million as the Chandler-based pharmaceutical firm works through bankruptcy filing proceedings. Insys will sell its naloxone and epinephrin.....»»

Category: topSource: bizjournalsAug 23rd, 2019

Evoke Pharma to Resubmit Gimoti™ NDA Based on FDA Meeting Minutes and Announces Second Quarter 2019 Financial Results

SOLANA BEACH, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that following receipt of U.S. Food and Drug .....»»

Category: earningsSource: benzingaAug 8th, 2019

Australian Medicinal Cannabis Producer THC Global Obtains Manufacturing License

Sydney, Australia-based medicinal cannabis manufacturer, THC Global Group announced Tuesday that it obtained another manufacturing license for its subsidiary THC Pharma Pty Ltd from the Australian Office of Drug Control. read more.....»»

Category: blogSource: benzingaJul 9th, 2019

Again, Durham pharma loses a drug development partner

Maybe third time would be the charm. One of Chimerix's development and commercial partners is out, disclosing this week it would be terminating a four-year-old licensing agreement after deciding to drop the Durham-based pharma's drug – the second t.....»»

Category: topSource: bizjournalsApr 5th, 2019

Why Is Purdue Settling Oklahoma Opioid Lawsuit for $275 Million?

Tuesday afternoon, the attorney general of Oklahoma is expected to announce that the state has reached a settlement with Purdue Pharma that will see the state receive a $275 million payout from the........»»

Category: blogSource: 247wallstMar 26th, 2019

How High Drug Prices and Big Lobbying Budgets Go Together for Big Pharma

Denmark-based diabetes drugmaker Novo Nordisk is a case study in the Washington 'discussion.' Thi.....»»

Category: europeSource: fortuneApr 26th, 2018

Merck to move scientists and money toward promising cancer drug

Profits stemming from a Merck & Co. cancer treatment exceeded expectations in 2017. So much so that the Kenilworth, N.J.-based pharma giant will devote more manpower to its development and shed other projects considered less promising. That's ac.....»»

Category: topSource: bizjournalsApr 17th, 2018

These new Pharma Bros are wreaking havoc on drug prices

A Chicago-based duo is selling a simple strategy — and companies they’ve worked with have raised prices on drugs as much as 4,116%......»»

Category: topSource: moneycentralApr 7th, 2018

Advocacy group agree to drop lawsuit against A.C."s PILOT settlement

Members of a New Jersey-based nonprofit advocacy group said it will drop its lawsuit challenging Atlantic City's PILOT settlement, just days after Atlantic County reportedly reached an agreement on the dollars it is slated to receive. PILOT, or the pay.....»»

Category: topSource: bizjournalsApr 30th, 2018

Japanese drug maker Takeda agrees to buy Ireland"s Shire

Japanese drugmaker Takeda has agreed to buy Ireland-based Shire for 46 billion pounds ($62.4 billion) in one of the biggest pharma deals to date......»»

Category: topSource: foxnewsMay 8th, 2018

Japanese drug maker Takeda to buy Ireland"s Shire

Japanese drugmaker Takeda has agreed to buy Ireland-based Shire for 46 billion pounds ($62.4 billion) in one of the biggest pharma deals to date......»»

Category: topSource: foxnewsMay 8th, 2018

GW Pharma"s Epidiolex Becomes First Cannabis-Based FDA-Approved Drug

As expected, the U.S. read more.....»»

Category: blogSource: benzingaJun 25th, 2018

Brainstorm Health: FDA Marijuana-Based Drug Approval, Pharma Innovation, GSK Shingles Vaccine

Brainstorm Health Daily: June 25, 2018 Happy Monday, readers--This is Sy. I was going to focus today’s essay on a striking statement from China on the opioid crisis--spe.....»»

Category: europeSource: fortuneJun 25th, 2018

Aquinox Pharma shares slide 73% premarket after cystitis drug trial fails to meet main goal

Aquinox Pharmaceuticals Inc. shares slid 73% in premarket trade Wednesday, after the Canadian-based biotech said a trial of a treatment for cystitis and severe bladder.....»»

Category: topSource: marketwatchJun 27th, 2018

UPDATE: GW Pharma shares up 2.4% premarket on news of positive trial for cannabis-based drug

GW Pharmaceuticals Inc. shar.....»»

Category: topSource: marketwatchNov 26th, 2018

Teva shares surge 5% on news of patent settlement with Neos over ADHD drug

Shares of generic drug maker Teva Pharmaceuticals Industries Ltd. rose about 5% Wednesday on news of a settlement and licensing agreement with Neos Therapeutics Inc. to resolve a patent dispute about a treatment for attention deficit disorders, or ADHD......»»

Category: topSource: marketwatchDec 26th, 2018

North Texas biotech settles litigation over ADHD drug

Grand Prairie-based Neos Therapeutics Inc. entered into a confidential settlement and licensing agreement with Teva Pharmaceuticals USA Inc. to resolve all ongoing litigation involving Neos' patents for its Cotempla product. The two companies got .....»»

Category: topSource: bizjournalsDec 27th, 2018

FDA rejects Sunovion"s experimental drug to treat Parkinson"s

The FDA has rejected a Parkinson's treatment from local drugmaker Sunovion Pharmaceuticals Inc., the company disclosed late Wednesday. Marlborough-based Sunovion, a subsidiary of the Japanese drug company Sumitomo Dainippon Pharma Co. Ltd., had asked.....»»

Category: topSource: bizjournalsJan 31st, 2019